HomeThemesTypesDBAbout
Showing: ◈ news×◈ patents×
Following the end of the Brexit transition period UK businesses are now having to pay ‘security bonds’ of £50,000 or more to courts in the European Union in order to litigate there, legal experts told City A.M. today.
The American Chamber of Commerce to the EU (AmCham-EU) published a cross-sectoral position paper on Tuesday turning the screw on the UK Government’s hard-line negotiating stance. Although it urges both sides to “work to mitigate disruption as much as possible”, the paper deals a devastating blow to Britain’s present strategy.
Brian Toohey, of the Pharmaceutical Research and Manufacturers of America trade group, spearheads PhRMA and recently told of the US drugs industry's predatory intentions.
Asked if Washington would be free to ‘jack up prices’, Foreign Secretary Dominic Raab replies ‘The Americans will take their decisions’.
Labour leader says documents leave Boris Johnson’s denials on post-Brexit US trade deal ‘in tatters’.
George Hollingbery, then trade minister, and John Saville, Her Majesty’s Consul General in Chicago met a pharmaceutical company's senior director in August last year to discuss a post-Brexit pact.